ClinicalTrials.Veeva

Menu

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland

F

Fondazione Epatocentro Ticino

Status

Completed

Conditions

Primary Biliary Cirrhosis

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02846896
SwissPBC - SASL36

Details and patient eligibility

About

PBC is a rare, autoimmune, cholestatic liver disease with genetic and environmental pathogenetic factors. Data about epidemiology of PBC in Switzerland are completely lacking. Epidemiology can be a powerful tool in yielding important clues as to burden and etiology of diseases. In addition, the investigators study will be the first one carried out in the country on PBC, and therefore will raise disease awareness and create a network.

Enrollment

501 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PBC patients living in Switzerland

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems